indmax
|
4’-OH-S |
8.4 (Krishna Machavaram, 2017; Yamazaki et al., 2019) |
6-OH-S |
3.6 (Krishna Machavaram, 2017) |
7-OH-S |
3.6 (Krishna Machavaram, 2017) |
8-OH-S |
5.5 (Yamazaki et al., 2019) |
10-OH-S |
16.0 (Yamazaki et al., 2019) |
4’-OH-R |
8.4 (Krishna Machavaram, 2017; Yamazaki et al., 2019) |
6-OH-R |
3.8 (Pelletier et al., 2013) |
7-OH-R |
7.8 (Pelletier et al., 2013; Krishna Machavaram, 2017; Yamazaki et al., 2019) |
8-OH-R |
5.5 (Yamazaki et al., 2019) |
10-OH-R |
16.0 (Yamazaki et al., 2019) |
indC50 (mg/L) |
4’-OH-S |
0.239 (Krishna Machavaram, 2017; Yamazaki et al., 2019) |
6-OH-S |
1.234 (Krishna Machavaram, 2017) |
7-OH-S |
1.234 (Krishna Machavaram, 2017) |
8-OH-S |
0.370 (Yamazaki et al., 2019) |
10-OH-S |
0.263 (Yamazaki et al., 2019) |
4’-OH-R |
0.239 (Krishna Machavaram, 2017; Yamazaki et al., 2019) |
6-OH-R |
0.181 (Pelletier et al., 2013) |
7-OH-R |
0.214 (Pelletier et al., 2013; Krishna Machavaram, 2017; Yamazaki et al., 2019) |
8-OH-R |
0.370 (Yamazaki et al., 2019) |
10-OH-R |
0.263 (Yamazaki et al., 2019) |
Rifampin effects on CLR (multiplication factor) |
S-warfarin |
1.30 (Cheng et al., 2022a) |
R-warfarin |
1.43 (Cheng et al., 2022a) |